Recent News
Jun 23, 2022
Blueprint Medicines Appoints Habib Dable to its Board of Directors
Events and presentations
Jun 30, 2022
Blueprint Medicines Conference Call
Jun 16, 2022
JMP Securities Life Sciences Conference
Our commitment to patients
At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve the lives of people with genomically defined diseases.
read onMeet the Blue Crew
Meet the Blue Crew
Rahul Kalathiya, Medical Science Liaison
My main responsibility is to build relationships with healthcare professionals, serving as a valuable resource and helping them make informed decisions for their patients. I provide education on our company’s treatments and current research efforts, including opportunities for investigator-initiated and company-sponsored trials. In addition, I gain insights on the real-world use of our therapies, current treatment landscape and future directions, and share these perspectives with our Medical Affairs organization so we can develop patient-centric strategies to address medical needs.
Read onWe aspire to pioneer multiple new scientific advances in disease biology and the design of precision therapies. To learn more about our scientific leadership and perspectives, visit The Lens.
read on“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat cancer.”Kate Haviland, Chief Executive Officer
“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat cancer.”Kate Haviland, Chief Executive Officer
Dare to be different
We believe diversity is the key to unlocking our full potential. We push boundaries and take well-calculated risks, committing courageously and wholeheartedly to what we believe in.
read on